|
KIAA1310 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.65650000277995E-08 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
1.63802305053196E-12 |
| Stage1-vs-Stage2 |
1.865620E-01 |
| Stage1-vs-Stage3 |
9.513800E-02 |
| Stage1-vs-Stage4 |
6.308400E-02 |
| Stage2-vs-Stage3 |
2.784400E-02 |
| Stage2-vs-Stage4 |
1.198380E-02 |
| Stage3-vs-Stage4 |
6.312000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
5.34440000032887E-07 |
| Normal-vs-Asian |
2.91759949533343E-10 |
| Caucasian-vs-AfricanAmerican |
4.130200E-01 |
| Caucasian-vs-Asian |
4.334200E-02 |
| AfricanAmerican-vs-Asian |
6.944400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.93018950717305E-14 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
2.692200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
1.6574519534629E-12 |
| Normal-vs-Age(81-100Yrs) |
1.73820999999075E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.491400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.318200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.739200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.997800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.000800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.898800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.91224999999129E-05 |
| Classical-VS-Follicular |
4.459400E-01 |
| Classical-VS-Other |
2.510000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
5.62130000000272E-05 |
| Tall-VS-Other |
4.561800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.336000E-01 |
| Follicular-VS-Normal |
5.19900011930474E-10 |
| Other-VS-Normal |
7.89010000000756E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.10862446895044E-15 |
| Normal-vs-N1 |
9.9475983006414E-14 |
| N0-vs-N1 |
6.954200E-02 |
|
|
